13F HOLDINGS REPORT
ENAVATE SCIENCES GP, LLC
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001415889-25-013132
Total Value
$132.7M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | IMMUNOME INC | IMNM | 4,768,583 | $32.1M | 24.18% |
| 2 | ZENAS BIOPHARMA INC | ZBIO | 3,761,359 | $29.7M | 22.39% |
| 3 | SIONNA THERAPEUTICS INC | SION | 2,478,030 | $25.9M | 19.53% |
| 4 | CAMP4 THERAPEUTICS CORP | CAMP | 3,785,802 | $15.1M | 11.41% |
| 5 | UPSTREAM BIO INC | UPB | 2,459,703 | $15.1M | 11.34% |
| 6 | COMPASS THERAPEUTICS INC | CMPX | 7,788,150 | $14.8M | 11.15% |